Defining a new immune deficiency syndrome: MAN2B2-CDG

Affiliations

• ¹ Center for Individualized Medicine, Department of Clinical Genomics, Mayo Clinic, Rochester, Minn.
• ² Hayward Genetics Center, Tulane University Medical School, New Orleans, La.
• ³ Division of Immunology, Boston Children's Hospital, Boston, Mass.
• ⁴ Biochemical Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minn.
• ⁵ Immunology Service, Department of Laboratory Medicine, National Institutes of Health, Bethesda, Md.
• ⁶ Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
• ⁷ Division of Hematology/Oncology, Boston Children's Hospital, Boston, Mass; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Mass.
• ⁸ New England Newborn Screening Program and the Department of Pediatrics, University of Massachusetts Medical School, Worcester, Mass.
• ⁹ Division of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Boston, Mass.
• ¹⁰ Section of Pediatric Allergy and Immunology, King Faisal Hospital and Research Center, Riyadh, Saudi Arabia.
• ¹¹ Palmieri Metabolic Disease Laboratory, The Children's Hospital of Philadelphia, Philadelphia, Pa. Electronic address: [email protected].
• ¹² Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. Electronic address: [email protected].
• ¹³ Center for Individualized Medicine, Department of Clinical Genomics, Mayo Clinic, Rochester, Minn. Electronic address: [email protected].